The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to point-of-care molecular diagnostics market will
help companies and investors design strategic landscapes.
infectious diseases was the
largest segment with a revenue share of
93.52% in
2023.
Horizon Databook has segmented the Global point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Point-of-Care Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Prenatal Testing
- Endocrinology
- Other Applications
- Hematology
- Complete blood count (CBC)
- Prothrombin time (PT)
- Partial Thromboplastin Time (PTT)
- Others
- Infectious Diseases
- CT/NG
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and drug-resistant TB POC
- HSV POC
- COVID-19
- Other Infectious Diseases
- Global Point-of-Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
- PCR-based
- Genetic Sequencing based
- Hybridization based
- Microarray based
- Global Point-of-Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2018-2030)
- Global Point-of-Care Molecular Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
- Decentralised Labs
- Hospitals
- Home care
- Assisted Living Healthcare Facilities
- Others
Reasons to
subscribe to Global point-of-care molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global point-of-care molecular diagnostics market databook
-
Our clientele includes a mix of point-of-care molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global point-of-care molecular diagnostics market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global point-of-care molecular diagnostics market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.